期刊文献+

苯磺酸氨氯地平联合雷米普利治疗老年原发性高血压临床观察 被引量:2

Observation on clinical effect of amlodipine besylate tablet combined with ramipril in elderly patients with primary hypertension
下载PDF
导出
摘要 目的探讨苯磺酸氨氯地平联合雷米普利治疗老年原发性高血压的临床效果。方法将97例老年原发性高血压患者随机分为联合用药组(A组)50例和单一用药组(B组)47例,B组患者给予单用苯磺酸氨氯地平治疗,A组患者采用苯磺酸氨氯地平联合雷米普利治疗。观察对比两组患者治疗前后收缩压(SBP)及舒张压(DBP)的变化情况,临床疗效及不良反应。结果 A组患者治疗总有效率(82.0%)显著高于B组患者(63.8%),两组比较差异有统计学意义(P<0.05),A组患者的临床疗效优于B组患者(P<0.05)。治疗后A组患者SBP及DBP均明显低于B组患者,两组比较差异有统计学意义(P<0.05或P<0.01)。结论苯磺酸氨氯地平联合雷米普利治疗老年原发性高血压患者疗效显著,不良反应轻微,值得推广应用。 Objective To explore the clinical effect of amlodipine besylate tablet combined with ramipril in elderly patients with primary hypertension. Methods 97 elderly patients with primary hypertension were randomly divided into combined treatment group( group A,n = 50) and single medication group( group B,n = 47),group B was given amlodipine besylate tablet only,while group A was given amlodipine besylate tablet combined with ramipril. SBP and DBP of the two groups were observed and compared before and after treatment,the curative effect and adverse reactions were also recorded. Results After treatment,the total effective rate was 82. 0% in group A,and 63. 8% in group B,there was significant difference between the two groups( P 〈 0. 05); the curative effect of group A was statistically better than that of group B( P 〈 0. 05). SBP and DBP in the group A were both statistically lower than that in group B( P 〈 0. 05). Conclusions Amlodipine besylate tablet combined with ramipril has significant effecacy on elderly patients with primary hypertension,adverse reactions is mild,which is worthy of popularization and application.
作者 于辉月
出处 《内科》 2014年第6期647-648,662,共3页 Internal Medicine
关键词 老年 原发性高血压 治疗 苯磺酸氨氯地平 雷米普利 Elderly primary hypertension Treatment Amlodipine besylate tablet Ramipril
  • 相关文献

参考文献5

二级参考文献20

  • 1霍建宏,张文兵.老年高血压患者脉压与左房构型改变的相关研究[J].中国现代医学杂志,2004,14(22):128-129. 被引量:4
  • 2池迎迎.抗高血压药物的应用分析[J].医药导报,2005,24(6):535-536. 被引量:21
  • 3刘英明,朱智明,曹毅,李贤峰,高连如,杨晔,卢才义,王士雯.阻断肾素-血管紧张素系统对高血压患者心房颤动发生危险的影响[J].中国心脏起搏与心电生理杂志,2005,19(4):264-266. 被引量:22
  • 4李莉.高血压治疗:从临床指南到临床实践[J].中国临床医生杂志,2007,35(3):67-71. 被引量:52
  • 5Authors/Task Force Members, Mancia G, Fagard R, et al. 2013 ESH/ESC guidelines for the management of arterial hy- pertension:the task force for the management of arterial hy- pertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). Eur Heart J,2013, 34:2159.
  • 6Wang Z, Liu Y, Liu J, et al. E selection gene polymorphisms are associated with essential hypertension: a case-control pilot study in a Chinese population. BMC Med Genet,2010,11 : 127.
  • 7Wang Z, Liu Y, Liu J, et al. HSG/Mirn2 gene polymorphism and essential hypertension: a case control association study in Chinese. J Atheroscler Thromb, 2011,18 : 24 31.
  • 8Lou Y, Liu J, Li Y, et al. Association study of the l?2-adrenergic receptor gene polymorphisms and hypertension in the northern Han Chinese. PLoS One, 2011,6 : e1 8590.
  • 9Calhoun DA,Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Dlood Pressure Research. Hypertension, 2008,51 : 1403-1419.
  • 10Schmieder RE, Redon J, Grassi G, et aL ESH position paper: renal denereation-an interventional therapy of resistant hyper tension. J Hypertension,2012,30:837 -841.

共引文献49

同被引文献11

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部